Press Releases
-
Independent Site Management Organisation Panthera prepares for COVID-19
Independent Site Management Organisation Panthera is working with sponsors who need to press ahead with trials which can be done safely.
Apr 5, 2020
-
Sharp Clinical Supports Development of Novel COVID-19 Vaccines and Treatments
Sharp Clinical, part of UDG Healthcare and a leading provider of global clinical supply services, has confirmed that it is involved in supporting six clinical trials related to COVID-19.
Apr 6, 2020
-
New Study Finds Global Clinical Trial Sites Continue to Face Financial Constraints, Directly Impacting Study Efficiencies
-
As Universities and Academic Institutions Face Unique Challenges in Reporting Clinical Trials, TrialAssure Responds by Offering Free Clinical Trial Transparency Tool
TrialAssure® announced today that it will offer academic institutions free access to TrialAssure REGISTRY—the premiere clinical trial disclosure reporting application.
Apr 6, 2020
-
Greenphire Launches Extension of its ConneX Solution, ConneX Patient Direct, as Trial Sites Seek Support in Response to COVID-19
-
Clinical Ink Donates Mobile Devices to Aid in Mental Tele-Health
Clinical Ink, a global clinical trial technology company, has made a commitment to donate several hundred mobile phones and tablets to Thrive Behavioral Health for individual and family mental tele-health services, which are largely replacing in-person sessions during the COVID-19 crisis.
Apr 13, 2020
-
Clinically-proven gamification app teaches positive inhaler technique; crucial for managing asthma
A newly validated app called Rafi-Tone, developed by clinicians in the UK, makes using an inhaler with a spacer easier and more fun for young children with wheeze or asthma symptoms.
Apr 13, 2020
-
Biological Specialty Company Launches At-home Blood Donation Service for COVID-19 Patients Who Want to Help Develop New Drugs and Vaccines
BSC is collecting blood samples from sick and recovered COVID-19 patients to assist in developing COVID-19 therapies, vaccines and diagnostic biomarkers.
Apr 14, 2020
-
ERT’s At-Home Cardiac Safety Assessment Ensures Clinical Trial Continuity
Company’s expertise, infrastructure and flexibility enable remote ECG assessment for fast-tracked COVID-19 vaccines /therapies and other critical pharmaceuticals
Mar 29, 2020
-
CD Bioparticles Announces Carbon-based Nanocages Production Services for Researchers
CD Bioparticles introduces carbon-based nanocages production services to global researchers.
Mar 29, 2020
-
PHARMASEAL Supports Life Science Businesses by Offering No Cost CTMS for COVID-19 Clinical Trials
PHARMASEAL International, provider of clinical trials management systems has today announced that it will offer the Engility® CTMS solution at no cost for COVID-19 Coronavirus clinical trials. The free offer to utilize Engility CTMS is open to biopharmaceutical organizations and academic institutions.
Mar 31, 2020
-
ERT Enables Clinical Trial Continuity through At-Home Respiratory Solutions
High-quality clinician-administered data collected during patient home visits advances respiratory trials throughout COVID-19 pandemic
Mar 31, 2020
-
Serimmune Announces Achievement of Research Milestone in Discovery and Development Collaboration with Merck
Serimmune, a leader in understanding the functional antibody repertoire’s role in human disease, today announced that the company has received a research milestone payment from Merck (known as MSD outside the United States and Canada) under its ongoing discovery and development collaboration agreement.
Apr 1, 2020
-
Zymewire Launches Directory Of Drug Development Experts With Services Available To Fight COVID-19
Zymewire announces the launch of CovidCollaborators.org, an online directory of expert, pro-bono, and discounted clinical development services being offered in the fight against COVID-19.
Apr 1, 2020
-
Noxopharm Investigating Potential COVID-19 Treatment
Noxopharm has identified a clinical trial opportunity that could help reduce the mortality rate of COVID-19.
Apr 1, 2020
-
FHI CLINICAL PROVIDING FULL-SERVICE CRO CAPABILITIES FOR CORONAVIRUS (COVID-19) CLINICAL TRIAL
FHI Clinical just announced it has partnered with Seattle-based Infectious Disease Research Institute (IDRI) to provide full-service CRO capabilities for an immunotherapy trial to combat moderate to severe cases of COVID-19.
Apr 1, 2020
-
OBVIOHEALTH LAUNCHES VIRTUAL COVID-19 SYMPTOMS & IMMUNE RESPONSE REGISTRY
-
Spring Bank Provides Update on Business Operations & Clinical Program Progress During COVID-19 Pandemic
The release announces an update on the company’s business operations in response to and as a result of the global COVID-19 pandemic; one of the announcements includes the Safety Review Committee for IV SB 11285 Phase 1a/1b trial recommends dose escalation to next planned dose level.
Apr 1, 2020
-
WCG Launches Program to Provide Clinical Research Professionals with Timely Information During the COVID-19 Pandemic
The initiative launches with a weekly webinar series featuring WCG experts and guest panelists, with a focus on communicating emerging best practices in real time.
Mar 22, 2020
-
CluePoints´ Central Statistical Monitoring Supports Business Continuity as Coronavirus Impacts Clinical Trial Operations
CluePoints, the premier provider of Risk-Based Trial Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced that it has seen a dramatic increase in demand for remote and centralized site monitoring amid the ongoing Coronavirus outbreak.
Mar 17, 2020